⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1277471 | 0.74 | — | — | |
| SCHEMBL5931813 | 0.61 | — | — | |
| SCHEMBL5931960 | 0.61 | — | — | |
| SCHEMBL11856419 | 0.55 | — | — | |
| SCHEMBL4608573 | 0.55 | — | — | |
| SCHEMBL5341409 | 0.54 | CNR2 (0.32) | — | |
| SCHEMBL7646195 | 0.53 | ATM (0.30) | — | |
| SCHEMBL29922219 | 0.53 | — | — | |
| SCHEMBL5350398 | 0.52 | ALDH1A1 (0.33) | — | |
| SCHEMBL5351523 | 0.52 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12491207-B2 | Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability | VANELTIX PHARMA, INC. (US) | 2025-12-09 | — | — | US | disclosed |
| US-20230137384-A1 | ARTICLE OF MANUFACTURE COMPRISING LOCAL ANESTHETIC, BUFFER, AND GLYCOSAMINOGLYCAN IN SYRINGE WITH IMPROVED STABILITY | URIGEN PHARMACEUTICALS, INC. | 2023-05-04 | — | — | US | disclosed |
| US-11491179-B2 | Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability | URIGEN PHARMACEUTICALS, INC. (US) | 2022-11-08 | — | — | US | disclosed |